Clinical Trial Update: Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI

View source ↗

Summary

Clinical trial evaluating a strategy using the SYNTAXII score for functional assessment in 3-vessel coronary artery disease with PCI has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 3 Vessel Coronary Artery Disease
• Cardiovascular Diseases
• Heart Diseases

Snippet

Sponsor: ECRI bv | Conditions: Heart Diseases, Cardiovascular Diseases | Status: COMPLETED | Results posted: 2022-06-16